A multicentre phase III randomised double blind placebo contolled trial of pravastatin added to first-line standard chemotherapy in patients with small cell lung cancer.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 18 Sep 2021

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

03 Dec 2014 Biomarkers information updated
15 Jan 2013 Planned end date changed from 31 Dec 2011 to 1 Jan 2012 as reported by ClinicalTrials.gov.
31 May 2012 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network record.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com